Actionable news
All posts from Actionable news
Actionable news in AMGN: Amgen Inc.,

Trade-Ideas: Amgen (AMGN) Is Today's Post-Market Leader Stock

Trade-Ideas LLC identified Amgen ( AMGN) as a post-market leader candidate. In addition to specific proprietary factors, Trade-Ideas identified Amgen as such a stock due to the following factors:

  • AMGN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $633.7 million.
  • AMGN is up 3.3% today from today's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in AMGN with the Ticky from Trade-Ideas. See the FREE profile for AMGN NOW at Trade-Ideas More details on AMGN: Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine. The stock currently has a dividend yield of 2%. AMGN has a PE ratio of 21. Currently there are 6 analysts that rate Amgen a buy, no analysts rate it a sell, and 8 rate it a hold. The average volume for Amgen has been 4.2 million shares per day over the past 30 days. Amgen has a market cap of...